Now Accepting Letters of Intent for 2027 Research Grants! Explore Funding Opportunities
Ataxia Centers of Excellence A designation to recognize centers that provide comprehensive care and services for individuals affected by Ataxia and their families. ATAXIA CENTERS OF EXCELLENCE DESIGNATION CRITERIA HOW Read More…
DRPLA Treatment Pipeline Tracking progress of the development of DRPLA therapies. Pipeline for DRPLA This is a visual tool created to show the progress of all DRPLA therapies that are Read More…
SCA2 Treatment Pipeline Tracking progress of the development of SCA2 therapies. Pipeline for SCA2 This is a visual tool created to show the progress of SCA2 therapies that are currently Read More…
SCA38 Treatment Pipeline Tracking progress of the development of SCA38 therapies. Pipeline for SCA38 This is a visual tool created to show the progress of SCA38 therapies that are currently Read More…
SCA17 Treatment Pipeline Tracking progress of the development of SCA17 therapies. Pipeline for SCA17 This is a visual tool created to show the progress of SCA17 therapies that are currently Read More…
SCA10 Treatment Pipeline Tracking progress of the development of SCA10 therapies. Pipeline for SCA10 This is a visual tool created to show the progress of SCA10 therapies that are currently Read More…
SCA8 Treatment Pipeline Tracking progress of the development of SCA8 therapies. Pipeline for SCA8 This is a visual tool created to show the progress of SCA8 therapies that are currently Read More…
SCA7 Treatment Pipeline Tracking progress of the development of SCA7 therapies. Pipeline for SCA7 This is a visual tool created to show the progress of SCA7 therapies that are currently Read More…
SCA6 Treatment Pipeline Tracking progress of the development of SCA6 therapies. Pipeline for SCA6 This is a visual tool created to show the progress of SCA6 therapies that are currently Read More…
SCA3 Treatment Pipeline Tracking progress of the development of SCA3 therapies. Pipeline for SCA3 This is a visual tool created to show the progress of SCA3 therapies that are currently Read More…
